Evidence map›Paper›PMID 36513581›Full record

ArticleHeart, lung & circulation2023

Impact of Nationwide COVID-19 Lockdowns on the Implantation Rate of Cardiac Implantable Electronic Devices.

Hannah K Wood-Kurland, Matthew Phelps, Jens Jakob Thune, Berit Philbert, Charlotte Ellen Larroudé, Morten Schou, Morten Lock Hansen, Gunnar H Gislason, Casper N Bang

Abstract read
In one paragraph

Article in Heart, lung & circulation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hannah K Wood-KurlandDepartment of Cardiology, Bispebjerg & Frederiksberg Hospitals, Copenhagen, Denmark; Department of Cardiology, Herlev-Gentofte Hospital, Hellerup, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. Electronic address: cnz174@alumni.ku.dk.
Matthew PhelpsDanish Heart Foundation, Copenhagen, Denmark.
Jens Jakob ThuneDepartment of Cardiology, Bispebjerg & Frederiksberg Hospitals, Copenhagen, Denmark.
Berit PhilbertDepartment of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Charlotte Ellen LarroudéDepartment of Cardiology, Herlev-Gentofte Hospital, Hellerup, Denmark.
Morten SchouDepartment of Cardiology, Herlev-Gentofte Hospital, Hellerup, Denmark.
Morten Lock HansenDepartment of Cardiology, Herlev-Gentofte Hospital, Hellerup, Denmark.
Gunnar H GislasonDepartment of Cardiology, Herlev-Gentofte Hospital, Hellerup, Denmark; Danish Heart Foundation, Copenhagen, Denmark.
Casper N BangDepartment of Cardiology, Bispebjerg & Frederiksberg Hospitals, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe COVID-19 pandemic resulted in a significant decrease in the number of hospital admissions for severe emergent cardiovascular diseases during lockdowns worldwide. This study aimed to determine the impact of both the first and the second Danish nationwide lockdown on the implantation rate of cardiac implantable electronic devices (CIEDs).

methodsWe retrospectively analysed the number of CIED implantations performed in Denmark and stratified them into 3-week intervals.

resultsThe total number of de novo CIED implantations decreased during the first lockdown by 15.5% and during the second by 5.1%. Comparing each 3-week interval using rate ratios, a significant decrease in the daily rates of the total number of de novo and replacement CIEDs (0.82, 95% CI [0.70, 0.96]), de novo CIEDs only (0.82, 95% CI [0.69, 0.98]), and non-acute pacemaker implantations (0.80, 95% CI [0.63, 0.99]) was observed during the first interval of the first lockdown. During the second lockdown (third interval), a significant decrease was seen in the daily rates of de novo CIEDs (0.73, 95% CI [0.55, 0.97]), and of pacemakers in total during both the second (0.78, 95% CI [0.62, 0.97]) and the third (0.60, 95% CI [0.42, 0.85]) intervals. Additionally, the daily rates of acute pacemaker implantation decreased during the second interval (0.47, 95% CI [0.27, 0.79]) and of non-acute implantation during the third interval (0.57, 95% CI [0.38, 0.84]). A significant increase was observed in the number of replacement procedures during the first interval of the second lockdown (1.70, 95% CI [1.04, 2.85]).

conclusionsOur study found only modest changes in CIED implantations in Denmark during two national lockdowns.

Indexed as

COVID-19Defibrillators, ImplantablePacemaker, ArtificialCommunicable Disease ControlHumansPandemicsRetrospective StudiesRisk FactorsCardiac resynchronisation therapyCardiovascular implantable electronic devicesCOVID-19Implantable cardioverter defibrillatorPacemaker

Identifiers

PMID36513581
PMCPMC9741195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.